SEELQ — Seelos Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Seelos Therapeutics Announces Pricing Of $5.55 Mln Public Offering
Brief: Seelos Therapeutics Announces Proposed Public Offering
Brief: Seelos Therapeutics Announces 1-For-30 Reverse Stock Split
Brief: Seelos Therapeutics Retains Canaccord Genuity In Connection With Review Of Potential Partnerships And Collaborations
Brief: Empery Asset Management, Lp Transmitted Letter To Management, Board Of Directors Of Seelos Therapeutics, Inc Alleging Material Misrepresentations
Brief: Seelos Therapeutics Announces Encouraging Data From An In Vivo Study Of Sls-005 In An Aggressive Preclinical Model Of Alzheimer's Disease
Brief: Seelos Therapeutics Announces Registered Direct Offering Of Common Stock And Warrants To Purchase Common Stock
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx
U.S. STOCKS ON THE MOVE-Lululemon, Copper miners, Gold miners
Seelos hits record low as experimental treatment for suicidal behavior fails in study
U.S. STOCKS ON THE MOVE-Exscientia, Fresh Track Therapeutics, Pinterest
Seelos falls as experimental treatment for suicidal behavior fails in study
Brief: Seelos Therapeutics Experimental Treatment For Suicidal Behaviour Fails In Mid-Stage Study
Brief: Seelos Therapeutics Files For Resale Of Up To 5.0 Mln Shares Of Common Stock By The Selling Stockholders - SEC Filing
Seelos Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Seelos Therapeutics Announces Close Of Enrollment Of Its Registration Directed Study Of SLS-002
Brief: Seelos Therapeutics Receives Nasdaq Notice On Not Regained Compliance With Rule 5550(A)(2)
Brief: Seelos Therapeutics Provides Clinical Update And Reports First Quarter 2023 Financial Results
Brief: Seelos Is Temporarily Pausing Additional Enrollment Of Patients In SLS-005-302 Study